Patients with a sarcoma belong to a group of patients with rare cancers.In addition to limited treatment options, there is a poor understanding of sarcomas. The main aim of the Radboud Biobank Sarcoma is to gain insight into prognostic and predictive factors of the different sarcomas. Biomaterial (blood and tissue) in combination with clinical data will be stored in this sub-biobank.
Want to know more about these subjects? Click on the buttons below for more news.
Related news items
Financial regulation for sub-biobanks15 September 2020
Sub-biobanks are not required to pay up-front for the processing and storage of biomaterials. The effectiveness of this pre-financing agreement however is dependent on adherence to the demands regarding delivery and processing according to the Radboud Biobank standard operating procedures.read more